1. MicroRNA-139 inhibits the proliferation and migration of osteosarcoma cells via targeting forkhead-box P2
   Chunan Zhong et al, 2017, Life Sciences CrossRef
2. miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase
   Wenkang Luan et al, 2017, Biochemical and Biophysical Research Communications CrossRef
3. miRNA signatures in childhood sarcomas and their clinical implications
   G. M. Viera et al, 2019, Clin Transl Oncol CrossRef
4. miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4.
   Feiya Du et al, 2019, Cell Death Dis CrossRef
5. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma
   Xingxing Sun et al, 2020, Biomedicine & Pharmacotherapy CrossRef
6. Long non‑coding RNA XIST serves an oncogenic role in osteosarcoma by sponging miR‑137
   Hui Li et al, 2018, Exp Ther Med CrossRef
7. Establishment of an miR‑137‑knockout cell model using CRISPR/Cas9 genome editing
   Wei Chen et al, 2018, Oncol Lett CrossRef
8. Circular RNA circPVT1 Contributes to Doxorubicin (DXR) Resistance of Osteosarcoma Cells by Regulating TRIAP1 via miR-137
   Dan Li et al, 2021, BioMed Research International CrossRef
9. Prognostic Value of miR-137 in Children with Medulloblastoma and its Regulatory Effect on Tumor Progression
   Wenyuan Ji et al, 2021, Neuromol Med CrossRef